Development of Endoscopic Treatment for Achalasia
POEM
1 other identifier
interventional
55
1 country
2
Brief Summary
Per Oral Endoscopic Myotomy (POEM); comparison of two surgical techniques division all the esophageal muscle layers versus division the inner circular muscle layer of the esophagus only.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2019
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 15, 2019
CompletedFirst Submitted
Initial submission to the registry
November 7, 2019
CompletedFirst Posted
Study publicly available on registry
November 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
May 8, 2024
May 1, 2024
7.7 years
November 7, 2019
May 7, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The proportion of patients who develop gastroesophageal reflux disease (GERD)
Measured as esophageal acid exposure (pH \<4) \> 4% of recorded time
1 year
Secondary Outcomes (5)
Esophageal emptying function
1 year
Eckardt score
1 year
RAND-36
1 year
Dysmotility
1 year
Gastrointestinal Symptom Rating Scale (GSRS)
1 year
Study Arms (2)
total division of the muscle layer
ACTIVE COMPARATORPOEM- total division of the circular muscle layer into the gastroesophageal junction
partial division of the muscle layer
ACTIVE COMPARATORPOEM - partial division of the circular muscle layer into the gastroesophageal junction
Interventions
Peroral endoscopic myotomy
Eligibility Criteria
You may qualify if:
- Newly diagnosed achalasia
- the patient should understand the nature and the purpose of the study and give informed consent
You may not qualify if:
- previous surgical treatment of achalasia
- inability to understand the contents of or follow the protocol
- other pathology as an explanation for the obstruction of the esophageal transition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Karolinska Institutet, Ersta Hospital
Stockholm, Region Stockholm, SE-116 91, Sweden
Karolinska Institutet
Stockholm, Stockholm County Council, 116 91, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anders Thorell, Professor
Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The randomization process is initiated after general anesthesia is induced and the group affiliation will be determined by opening of a sealed envelope specifying the group assignment. The information of group allocation is stored in a closed envelope kept in a locked archive until the study is completed.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 7, 2019
First Posted
November 27, 2019
Study Start
April 15, 2019
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
May 8, 2024
Record last verified: 2024-05